🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dawn Kuszynski

Therapeutics Systems Research Laboratories (United States)

ORCID: 0000-0002-3182-8551

Also affiliated with Michigan State University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “RETRACTED: Novel C‐terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self‐renewal, and epithelial–mesenchymal transition”.

RETRACTED: Novel C‐terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self‐renewal, and epithelial–mesenchymal transition

Molecular Oncology(2020)10.1002/1878-0261.12686

N/A

0DataRank · unranked

19 citations

Patrick T. Grogan, Ton Wang, Joseph Bazzill, Ang Zuo, Peter White +6 more

Clopidogrel treatment inhibits P2Y2-Mediated constriction in the rabbit middle cerebral artery

European Journal of Pharmacology(2021)10.1016/j.ejphar.2021.174545

N/A

0DataRank · unranked

4 citations

Barbara Christian, Anne M. Dorrance, Adam Lauver, Dawn Kuszynski

Re-Evaluation of Combinational Efficacy and Synergy of the Italian Protocol In Vitro: Are We Truly Optimizing Benefit or Permitting Unwanted Toxicity?

Biomedicines(2021)10.3390/biomedicines9091190

N/A

0DataRank · unranked

1 citations

Reid McCallister, Dawn Kuszynski, Mark S. Cohen, Chitra Subramanian

>Clopidogrel Rescues the Adverse Cerebral Vascular Effects Associated with Angiotensin II‐Induced Hypertension

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r3598

N/A

0DataRank · unranked

0 citations

Anne M. Dorrance, Adam Lauver, Dawn Kuszynski